Ethomerzol as antioxidant

   
Mironova O.P.1, Zarubina I.V.1, Shabanov P.D.1

1. Military Medical Academy
Section: Experimental/Clinical Study
PubMed Id: 16119095
Year: 2003  Volume: 49  Issue: 5  Pages: 434-442
Ethomerzol (25 mg/kg, intraperitaneally, 30 min before hypoxia) prevents lipid peroxidation activation and antioxidant system suppression in brain and liver of albino rats at acute hypoxia. Injection of ethomerzol decreases accumulation of conjugated diense and malondialdehyde, increases the levels of thiols and the activities of the antioxidant enzymes in the brain and the liver. In the model biological systems in vitro ethomerzol (0.01-40 mM) inhibits of Fe2+-induced ascorbate-dependent lipid peroxidation in a non-metabolizing model, such as liposomes, similar to DMSO and Fe2+-induced ascorbate- and NADPH-dependent lipid peroxidation in the brain homogenates similar to EDTA. Thus ethomerzol exhibits antioxidant properties.
Download PDF:  
Citation:

Mironova, O. P., Zarubina, I. V., Shabanov, P. D. (2003). Ethomerzol as antioxidant. Biomeditsinskaya Khimiya, 49(5), 434-442.
References  
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)